Physician profile
Ningjing Li
NPI 1629457809
$966.63
in general payments reported to CMS, 2019-2025
10 companies · $95.11 in 2025
The $95.11 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $339 · 2023: $72.74 · 2024: $460 · 2025: $95.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583 · Education: $45.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.74 |
| Education | $45.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $180.12 | 2023-2024 | |
| Seagen INC. | $154.94 | 2022 | |
| Gilead Sciences, INC. | $114.00 | 2024 | Trodelvy |
| Beigene USA, INC. | $109.01 | 2024 | Brukinsa |
| E.R. Squibb & Sons, L.L.C. | $102.00 | 2024 | Opdivo |
| Incyte Corporation | $96.73 | 2022 | |
| Karyopharm Therapeutics INC. | $87.10 | 2022 | |
| Adc Therapeutics America, INC. | $59.37 | 2023-2025 | |
| Lilly USA, LLC | $32.44 | 2025 | Verzenio, Jaypirca |
| Genmab U.S., INC. | $30.92 | 2025 | Epkinly |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ningjing Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.